638. Perception, Awareness and Acceptance of Humanpapilloma Virus (HPV) Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years
Session: Oral Abstract Session: Vaccines for all Ages
Friday, October 4, 2013: 8:30 AM
Room: The Moscone Center: 200-212
Background: Human papillomavirus (HPV) is the most common viral sexually transmitted infection (STI) in the United States.  HPV quadrivalent vaccine was licensed for use in boys/young men ages 9 to 26 yrs in Oct 2009; vaccination rates for boys remains extremely low (<3%). The objective of this study was to gain an understanding of the perceptions of HPV disease, and acceptance/barriers to HPV vaccine by parents of boys 9 to 18 yrs of age, in order to develop strategies to improve vaccination rates.

Methods: A 20 question, anonymous, survey was administered to parents of boys aged 9 to 18 yrs who obtained their medical care from several private pediatricians’ offices and several public health clinics in Chicago. The survey tool assessed basic demographic data of the parent, education and income level, awareness and perceived risk for HPV infection, and awareness of, acceptance/barriers to HPV vaccination.

Results: There were 286 and 230 completed surveys from public health clinic parents (PHCP) and private physicians’ offices parents (PPOP) respectively. Median age of parent completing survey was 45.50 yrs (PPOP) vs. 38 yrs (PHCP); the majority were female. No differences between groups for median age of male (M) child (13 yrs). The majority of PPOP were white (77.39%) while the majority of PHCP were Hispanic (62.24%). 82.1% PPOP vs. 15.41% PHCP were college graduates, p<0.0001. 67.8% PHCP had family income of ≤ $25,000 vs. 5.6% PPOP, p<0.0001.

91.74% PPOP vs. 65.03% PHCP heard of HPV, p<0.0001; less than 40% and less than 20% knew that HPV was associated with genital warts and male oral/anogenital cancers, respectively. 76.52% PPOP vs. 50.32% PHCP knew HPV was sexually transmitted, p<0.0001. 86.96% PPOP vs. 55.24% PHCP had heard of HPV vaccine, p<0.0001. 43.04% PPOP and 26.92% PHCP knew that the HPV vaccine was available for boys; no difference between percent PPOP (44.35%) vs PHCP (45.10%) that would vaccinate their sons. For both groups, healthcare provider recommendation was  primary influence for getting vaccination. The major barrier to vaccination lack of information on HPV disease/vaccine.

Conclusion: The majority of PPOP and PHCP rely on primary healthcare provider for vaccine recommendations. Healthcare provider education on recommendations/indications for HPV4 vaccine use is needed to improve vaccination rates.

Tina Tan, MD, FIDSA, Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL and Melvin Gerbie, MD, Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL


T. Tan, Merck: Grant Investigator, Grant recipient and Research grant

M. Gerbie, Merck: Grant Investigator, Grant recipient and Research grant

See more of: Vaccines for all Ages
See more of: Oral Abstract Session
Previous Abstract | Next Abstract >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.